HomeTOP STORIESSanofi bets up to $1.53B to license blood cancer drug from Sino... Sanofi bets up to $1.53B to license blood cancer drug from Sino Biopharma unit By rogerjudd March 4, 2026 FacebookTwitterPinterestWhatsApp Post Content Previous articleHow Kennedy Is Trying to Revamp Medical SchoolNext articleTELUS invests in AST SpaceMobile to launch space-based cellular service across Canada latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
